Timing of intubation in COVID-19 is controversial. We sought to determine the association of the ROX (Respiratory rate–OXygenation) index defined as divided by divided by breathing frequency at the time of intubation with clinical outcomes.
METHODS:
We conducted a retrospective cohort study of patients with COVID-19 who were intubated by using a database composed of electronic health record data from patients with COVID-19 from 62 institutions. Multivariable logistic regression was used to evaluate the impact of ROX index score on mortality. We analyzed the ROX index as a continuous variable as well as a categorical variable by using cutoffs previously described as predicting success with high-flow nasal cannula.
RESULTS:
Of 1,087 subjects in the analysis group, the median age was 64 years, and more than half had diabetes; 55.2% died, 1.8% were discharged to hospice, 7.8% were discharged to home, 27.3% were discharged to another institution, and 7.8% had another disposition. Increasing age and a longer time from admission to intubation were associated with mortality. After adjusting for sex, race, age, comorbidities, and days from admission to intubation, an increasing ROX index score at the time of intubation was associated with a lower risk of death. In a logistic regression model, each increase in the ROX index score by 1 at the time of intubation was associated with an 8% reduction in odds of mortality (odds ratio 0.92, 95% CI 0.88–0.95). We also found an odds ratio for death of 0.62 (95% CI 0.47–0.81) for subjects with an ROX index score ≥ 4.88 at the time of intubation.
CONCLUSIONS:
Among a cohort of subjects with COVID-19 who were ultimately intubated, a higher ROX index at the time of intubation was positively associated with survival.
KlompasM. Potential strategies to prevent ventilator-associated events. Am J Respir Crit Care Med, 2015; 192(12):1420-1430.
2.
DevlinJW, SkrobikY, GelinasC, NeedhamDM, SlooterAJC, PandharipandePP, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med, 2018; 46(9):e825-e873.
3.
KatiraBH. Ventilator-induced lung injury: classic and novel concepts. Respir Care, 2019; 64(6):629-637.
Husain-SyedF, SlutskyAS, RoncoC. Lung-kidney cross-talk in the critically ill patient. Am J Respir Crit Care Med, 2016; 194(4):402-414.
6.
BrochardL, SlutskyA, PesentiA. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med, 2017; 195(4):438-442.
7.
CrucesP, RetamalJ, HurtadoDE, ErranzB, DíazB. A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection. Crit Care, 2020; 24(1):494.
8.
HochbergCH, SemlerMW, BrowerRG. Oxygen toxicity in critically ill adults. Am J Respir Crit Care Med, 2021; 204(6):632-641.
BrownCAIII, MosierJM, CarlsonJN, GibbsMA. Pragmatic recommendations for intubating critically ill patients with suspected COVID-19. J Am Coll Emerg Physicians Open, 2020; 1(2):80-84.
13.
TobinMJ, LaghiF, JubranA. Caution about early intubation and mechanical ventilation in COVID-19. Ann Intensive Care, 2020; 10(1):78.
14.
VoshaarT, StaisP, KöhlerD, DellwegD. Conservative management of COVID-19 associated hypoxaemia. ERJ Open Res, 2021; 7(1):00026-2021.
15.
PetrilliCM, JonesSA, YangJ, RajagopalanH, O’DonnellL, ChernyakY, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ, 2020; 369:m1966.
16.
ZhouF, YuT, DuR, FanG, LiuY, LiuZ, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020; 395(10229):1054-1062.
17.
HarrisonSL, Fazio-EynullayevaE, LaneDA, UnderhillP, LipGYH. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis. PLoS Med, 2020; 17(9):e1003321.
18.
KompaniyetsL, GoodmanAB, BelayB, FreedmanDS, SucoskyMS, LangeSJ, et al. Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death - United States, March-December 2020. MMWR Morb Mortal Wkly Rep, 2021; 70(10):355-361.
19.
ChanL, ChaudharyK, SahaA, ChauhanK, VaidA, ZhaoS, et al. Mount Sinai COVID Informatics Center (MSCIC). AKI in hospitalized patients with COVID-19. J Am Soc Nephrol, 2021; 32(1):151-160.
20.
RECOVERY Collaborative Group, HorbyP, LimWS, EmbersonJR, MafhamM, BellJL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med, 2021; 384(8):693-704.
21.
BeigelJH, TomashekKM, DoddLE, MehtaAK, ZingmanBS, KalilAC, et al. ACTT-1 Study Group Members. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med, 2020; 383(19):1813-1826.
22.
HymanJB, LeibnerES, TandonP, EgorovaNN, Bassily-MarcusA, Kohli-SethR, et al. Timing of intubation and in-hospital mortality in patients with coronavirus disease 2019. Crit Care Explor, 2020; 2(10):e0254.
23.
DupuisC, BouadmaL, de MontmollinE, Goldgran-ToledanoD, SchwebelC, ReignierJ, et al. Association between early invasive mechanical ventilation and day-60 mortality in acute hypoxemic respiratory failure related to coronavirus disease-2019 pneumonia. Crit Care Explor, 2021; 3(1):e0329.
24.
PandyaA, KaurNA, SacherD, O'CorragainO, SalernoD, DesaiP, et al. COVID-19 Research Group. Ventilatory mechanics in early vs late intubation in a cohort of coronavirus disease 2019 patients with ARDS: a single center's experience. Chest, 2021; 159(2):653-656.
25.
PapoutsiE, GiannakoulisVG, XourgiaE, RoutsiC, KotanidouA, SiemposII. Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies. Crit Care, 2021; 25(1):121.
26.
Hernandez-RomieuAC, AdelmanMW, HocksteinMA, RobichauxCJ, EdwardsJA, FazioJC, et al. Emory COVID-19 Quality and Clinical Research Collaborative. Timing of intubation and mortality among critically ill coronavirus disease 2019 patients: a single-center cohort study. Crit Care Med, 2020; 48(11):e1045-e1053.
27.
RocaO, CaraltB, MessikaJ, SamperM, SztrymfB, HernandezG, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med, 2019; 199(11):1368-1376.
28.
ZucmanN, MullaertJ, RouxD, RocaO, RicardJD. Contributors. Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure. Intensive Care Med, 2020; 46(10):1924-1926.
29.
Colaianni-AlfonsoN, MontielG, Castro-SayatM, SirotiC, Laura VegaM, ToledoA, et al. Combined noninvasive respiratory support therapies to treat COVID-19. Respir Care, 2021; 66(12):1831-1839.
30.
VegaML, DongilliR, OlaizolaG, ColaianniN, SayatMC, PisaniL, et al. COVID-19 pneumonia and ROX index: time to set a new threshold for patients admitted outside the ICU. Pulmonology, 2022; 28(1):13-17.
31.
MyersLC, MarkD, LeyB, GuarnieriM, HofmeisterM, PaulsonS, et al. Validation of respiratory rate-oxygenation index in patients with COVID-19-related respiratory failure. Crit Care Med, 2022. [Epub ahead of print].
32.
ChandelA, PatoliaS, BrownAW, CollinsAC, SahjwaniD, KhangooraV, et al. High Flow nasal cannula therapy in COVID-19: Using the ROX index to predict success. Respir Care, 2021; 66(6):909-919.
33.
MukhtarA, RadyA, HasaninA, LotfyA, El AdawyA, HusseinA, et al. Admission SpO2 and ROX index predict outcome in patients with COVID-19. Am J Emerg Med, 2021; 50:106-110.
34.
SulimanLA, AbdelgawadTT, FarragNS, AbdelwahabHW. Validity of ROX index in prediction of risk of intubation in patients with COVID-19 pneumonia. Adv Respir Med, 2021; 89(1):1-7.
35.
PrakashJ, BhattacharyaPK, YadavAK, KumarA, TuduLC, PrasadK. ROX index as a good predictor of high flow nasal cannula failure in COVID-19 patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis. J Crit Care, 2021; 66:102-108.
36.
QureshiAI, BasketWI, HuangW, ShyuD, MyersD, RajuM, et al. Facilitating the study of relationships between COVID-19 and cardiovascular health outcomes using Cerner Real-World COVID-19 deidentified dataset. Health Care Res J, 2020; 1(1):17-28.
37.
FuentesS, ChowdhuryYS. Fraction of inspired oxygen. Treasure Island (FL): StatPearls Publishing; 2020.
38.
MehtaRL, KellumJA, ShahSV, MolitorisBA, RoncoC, WarnockDG, LevinA. Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care, 2007; 11(2):R31.
39.
FerreiraFL, BotaDP, BrossA, MélotC, VincentJL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA, 2001; 286(14):1754-1758.
40.
LambdenS, LaterrePF, LevyMM, FrancoisB. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care, 2019; 23(1):374.
41.
TorresLK, HoffmanKL, OromendiaC, DiazI, HarringtonJS, SchenckEJ, et al. Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation. Thorax, 2021; 76(12):1176-1185.
42.
RocaO, MessikaJ, CaraltB, García-de-AciluM, SztrymfB, RicardJD, MasclansJR. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: the utility of the ROX index. J Crit Care, 2016; 35:200-205.
43.
TobinMJ, JubranA, LaghiF. Misconceptions of pathophysiology of happy hypoxemia and implications for management of COVID-19. Respir Res, 2020; 21(1):249.
44.
DhontS, DeromE, Van BraeckelE, DepuydtP, LambrechtBN. Conceptions of the pathophysiology of happy hypoxemia in COVID-19. Respir Res, 2021; 22(1):12.
45.
SafeIP, LacerdaMVG, Almeida ValFF, SampaioVS, HajjarLA, Brito-SousaJD, et al. Severe hypoxemia with normal heart and respiratory rate in early-stage coronavirus disease 2019 patients: the “happy hypoxemia phenomenon.”. Clin Infect Dis, 2021; 73(3):e856-e858.
46.
FinkDL, GoldmanNR, CaiJ, El-ShakankeryKH, SismeyGE, Gupta-WrightA, TaiCX. Ratio of oxygen saturation index to guide management of COVID-19 pneumonia. Ann Am Thorac Soc, 2021; 18(8):1426-1428.
47.
TsolakiVS, ZakynthinosGE, MantzarlisKD, DeskataKV, PapadontaM-E, GerovasileiouES, et al. Driving pressure in COVID-19 acute respiratory distress syndrome is associated with respiratory distress duration before intubation. Am J Respir Crit Care Med, 2021; 204(4):478-481.
48.
AmatoMBP, MeadeMO, SlutskyAS, BrochardL, CostaEL, SchoenfeldDA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med, 2015; 372(8):747-755.
49.
WettsteinRB, ShelledyDC, PetersJI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care, 2005; 50(5):604-609.
